| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 03/24/2004 | EP1299384B1 Indole derivatives useful for the treatment of cns disorders |
| 03/24/2004 | EP1296700A4 Anti-carcinogenic activity of hydroxylated chalcone compounds extracted from licorice root |
| 03/24/2004 | EP1252164B1 Method for producing 6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizine-5-yl acetic acid |
| 03/24/2004 | EP1239897B1 Tissue regenerative composition |
| 03/24/2004 | EP1231934B1 Methods of inhibiting atrophy or promoting hypertrophy |
| 03/24/2004 | EP1221936B1 Cosmetic compositions containing mulberry extract and retinoids |
| 03/24/2004 | EP1214296B1 Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivatives which elevate pyruvate dehydrogenase activity |
| 03/24/2004 | EP1196416B1 Substituted purine derivatives as inhibitors of cell adhesion |
| 03/24/2004 | EP1143964B1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission |
| 03/24/2004 | EP1140895B1 Thiopyran compounds as inhibitors of mmp |
| 03/24/2004 | EP1124809B1 Benzoylpyridazines |
| 03/24/2004 | EP1082110B1 Use of compounds for the elevation of pyruvate dehydrogenase activity |
| 03/24/2004 | EP1047690B1 Heterocyclic ether and thioether compounds useful in controlling chemical synaptic transmission |
| 03/24/2004 | EP1033981B1 Formulations and methods for reducing toxicity of antineoplastic agents |
| 03/24/2004 | EP0922036B1 Arylalkanoyl pyridazines |
| 03/24/2004 | EP0869970B1 Endothelial cell proliferation inhibitor and its use |
| 03/24/2004 | EP0850319B1 Method for modulating cell apoptosis |
| 03/24/2004 | EP0777494B1 Human chemokine polypeptides |
| 03/24/2004 | CN1484649A Stabilized pharmaceutical composition in lyophilized form |
| 03/24/2004 | CN1484646A Mikanolide derivatives their preparation and therapeutic uses |
| 03/24/2004 | CN1484644A Novel 7-azaindoles use thereof as phosphodiesterase 4 inhibitors and method for producing the same |
| 03/24/2004 | CN1484642A Excitatory amino acid receptor antagonists |
| 03/24/2004 | CN1484640A Quinzolone derivatives as alpha IA/B adrenergic receptor antagonists |
| 03/24/2004 | CN1484639A Geldanamycin derivative and method of treating cancer same |
| 03/24/2004 | CN1484638A I-aryl-or-I-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-b ligands |
| 03/24/2004 | CN1484525A Combinations of drugs (E. G chlorpromazine and pentamidine) for the treatment of neoplastic disorders |
| 03/24/2004 | CN1483782A Adhesive |
| 03/24/2004 | CN1483729A Method for preparing 5-phenoxymethoy 1-2-ephedroxane |
| 03/24/2004 | CN1483472A Health care products for delaying senility and preparation method thereof |
| 03/24/2004 | CN1483439A Preparation for treating chronic exhaustion syndrome and process for preparing same |
| 03/24/2004 | CN1483438A Auti-senility medicine and preparation process thereof |
| 03/24/2004 | CN1483437A Nux-vomica seed slow-released preparation and proless for preparing same |
| 03/24/2004 | CN1142936C Condensed thienopyrimidines with phosphodiesterase-V inhibiting action, preparation process and use thereof |
| 03/24/2004 | CN1142934C Metallocorrinoids as biologically compatible carriers of pharmocological agents |
| 03/24/2004 | CN1142928C Synthesis and use of retinoid compounds having negative hormone and/or antagonist activities |
| 03/24/2004 | CN1142920C Quinazoline derivatives and pharmaceutical compositions containing them and preparation process and use |
| 03/24/2004 | CN1142913C Tetrahydroisoquinolinealkanol derivatives and pharmaceutical compositions contg. same |
| 03/24/2004 | CN1142912C Amide derivs, useful as inhibitors for production of cytokines |
| 03/24/2004 | CN1142910C Amide compounds |
| 03/24/2004 | CN1142793C Epoxy-steroidal aldosterone antagonist and angiotensin 2 antagonist combination therapy for treatment of congestive heart failure |
| 03/24/2004 | CN1142785C Antifatigue capsule |
| 03/24/2004 | CN1142777C Use of oxazolidinone derivative for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy |
| 03/24/2004 | CN1142773C Transdermal terapeutic system which contains D2 agonist and which is provided for treating parkinsonism, and method for production thereof |
| 03/24/2004 | CN1142753C Skin patches for providing testosterone |
| 03/23/2004 | US6710209 Heteroaryl-substituted quinolin-2-one derivatives useful as anticancer agents |
| 03/23/2004 | US6710165 Membrane protein for use in the treatment of allergies, parkinson's, alzheimer's and apoptitic defects |
| 03/23/2004 | US6710163 Compounds that bind single-stranded dna and rna strands to form stable hybrids; bind complementary single-stranded dna and rna strands more strongly than corresponding dna |
| 03/23/2004 | US6710084 Administering to the subject an effective anti-inflammatory amount of a lipoxin analog |
| 03/23/2004 | US6710071 Such as ((3-4-(difluoro(phenyl)methyl)phenoxyl-3-phenylpropyl)methylamino)acetic acid; for the enhancement of cognition and the treatment of scizophrenia and other psychoses |
| 03/23/2004 | US6710069 1-aryl- or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 03/23/2004 | US6710067 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/23/2004 | US6710063 Activators of PPAR delta |
| 03/23/2004 | US6710061 Selective serine protease or dual-serine protease inhibitors of factor xa and tryptase |
| 03/23/2004 | US6710058 Use as anticoagulant agents for therapy and prophylaxis ofthromboembolic disorders |
| 03/23/2004 | US6710057 Inhibitors of factor xa, as anticoagulants for prophylaxis and treatment of thromboembolic disorders |
| 03/23/2004 | US6710056 Pharmaceutically acceptable salts thereof have an excellent antagonistic effect against activated blood coagulation factor vii. |
| 03/23/2004 | US6710054 Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents |
| 03/23/2004 | US6710052 Anticancer agents |
| 03/23/2004 | US6710048 Selective inhibitors of vascular endothelial growth factor receptor tyrosine kinase; to treat solid-tumor cancers, angiogenesis, diabetic retinopathy, rheumatoid arthritis, endometriosis and psoriasis |
| 03/23/2004 | US6710047 Phthalazines with angiogenesis inhibiting activity |
| 03/23/2004 | US6710043 Possess the potentiation of the cholinergic activity |
| 03/23/2004 | US6710042 Human NK3 receptor-selective antagonist compounds, method for obtaining them and pharmaceutical compositions containing them |
| 03/23/2004 | US6710028 Method for treating disturbances in iron metabolism using a combination of erythropoietin and iron |
| 03/23/2004 | US6710026 Diabetes |
| 03/23/2004 | US6709864 Composition comprising isolated human mesenchymal stem cells in biocompatible matrix which supports differentiation and maturation of stem cells into adipocytes |
| 03/23/2004 | US6709842 DNA encoding a growth factor specific for epithelial cells |
| 03/23/2004 | US6709837 Reagent for studies relating to the differentiation, growth and survival of animal cells, and may also be useful as a drug |
| 03/23/2004 | US6709831 DNA encoding mammalian neuropeptide FF (NPFF) receptors and uses thereof |
| 03/23/2004 | US6709663 Topical emulsion; quaternary ammonium salt emulsifier |
| 03/23/2004 | CA2263319C Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/23/2004 | CA2168432C Piperazine compounds used in therapy |
| 03/18/2004 | WO2004023138A1 Method of screening remedy for aids |
| 03/18/2004 | WO2004022752A1 Smg-1-binding protein and method of screening substance controlling its activity |
| 03/18/2004 | WO2004022750A1 Novel diagnostic and therapeutic methods and reagents therefor |
| 03/18/2004 | WO2004022727A1 Probiotic bacterium: lactobacillus fermentum |
| 03/18/2004 | WO2004022582A1 Peptidomimetic drugs |
| 03/18/2004 | WO2004022569A1 Akt inhibitors, pharmaceutical compositions, and uses thereof |
| 03/18/2004 | WO2004022557A1 Novel benzonaphthyridines |
| 03/18/2004 | WO2004022556A1 Aza-bicycloalkyl ethers and their use as alpha7-nachr agonist |
| 03/18/2004 | WO2004022553A1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING IκB KINASE |
| 03/18/2004 | WO2004022551A1 Furan or thiophene derivative and medicinal use thereof |
| 03/18/2004 | WO2004022545A1 Protective agents for transplanted organ |
| 03/18/2004 | WO2004022543A1 Preventive and/or therapeutic drugs for inflammatory intestinal diseases |
| 03/18/2004 | WO2004022537A2 Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands |
| 03/18/2004 | WO2004022535A1 Acrylamide derivatives |
| 03/18/2004 | WO2004022533A1 Novel vinyl carboxylic acid derivatives and their therapeutical use |
| 03/18/2004 | WO2004022529A2 Diarylurea derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2004022526A1 Cathepsin cysteine protease inhibitors |
| 03/18/2004 | WO2004022525A1 Amide derivatives and their use as chloride channel blockers |
| 03/18/2004 | WO2004022523A2 1, 3-diamino-2-hydroxypropane prodrug derivatives |
| 03/18/2004 | WO2004022128A2 Liquid aerosol formulations and aerosol generating devices and methods for generating aerosols |
| 03/18/2004 | WO2004022045A1 Hypogastric and/or perineal pain-relieving agent |
| 03/18/2004 | WO2004022041A2 Treatment of non-allergic rhinitis by means of selective phosphodiesterase-4 inhibitors |
| 03/18/2004 | WO2004022032A2 Pharmaceutical dosage form comprising a sulfite compound |
| 03/18/2004 | WO2004021968A2 Solution for ungual application |
| 03/18/2004 | WO2004012733A3 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 03/18/2004 | WO2004009596A3 Pyrazolopyrimidines as kinase inhibitors |
| 03/18/2004 | WO2004009583A3 Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor |
| 03/18/2004 | WO2004007697A3 Methods of implanting mesenchymal stem cells for tissue repair and formation |
| 03/18/2004 | WO2004005286A3 Viral inhibitors |